Sales revenue remains a reliable metric for launch success, but it’s not the only launch KPI pharma teams should be tracking. Sales figures alone tell just a fraction of the whole story, with launch success shaped well before the first scripts are written, and continuing to be defined long after launch day has passed. Sales revenue can reveal whether a new therapy was a hit or a flop – and may appease shareholders – but it won’t explain why.
This blog will explore five critical KPIs pharma teams should be tracking to capture a more holistic picture of launch performance beyond sales metrics alone. By adopting a broader KPI framework that includes metrics such as stakeholder engagement quality, speed to insight, and competitive agility, launch leaders can spot risks earlier, adapt faster, and sustain momentum across the product lifecycle.
KPI #1: Stakeholder engagement quality
Who are the key opinion leaders (KOLs) your teams approach pre-launch? How do you identify them, and how do you engage them? Measuring stakeholder engagement quality ensures you’re drawing insights from a diverse pool of experts – not relying on the same familiar faces.
You can use network analytics to assess the depth of your stakeholder engagement – are you engaging with the full spectrum of experts within your disease community? – while you can also track response rates, advisory board participation statistics, stakeholder diversity, and more.
“While identifying the appropriate stakeholders for an initiative, be mindful of having a balance, not only of experience and expertise, but also gender, race, ethnicity, and perspective. Consider the involvement of patients and/or caregivers as key stakeholders.” –ScienceDirect
KPI #2: Speed to insight
How quickly do signals pass through your organization? How long does it take to gather, synthesize, and analyze data before you’re ready to extract insights capable of informing decision-making? The quicker your speed to insight, the more agilely and efficiently your organization is operating. A slow speed to insight shows that it takes too long for medical and commercial teams to act on feedback – highlighting opportunities for greater efficiency.
“Faster insights enable businesses to make more timely decisions. This is particularly important in situations where data is time-sensitive, and delays can result in missed opportunities or increased risks.” –Medium
KPI #3: Message resonance & scientific validation
Your sales figures might be indicative of patient and HCP sentiment, but they won’t tell the whole story. Have patients and HCPs heard your launch narratives? And if they have, did they resonate with them? Even if your messages are getting through, are they consistent across all markets and channels? Is your brand trusted, or viewed favorably versus your competitors?
Tools such as social listening can help to capture the unbiased opinions of patients and HCPs. What do they really think about your therapies, your brand, and your competitors? Strong revenues today don’t guarantee strong revenues tomorrow. Measuring message resonance and scientific validation ensures long-term impact, even when topline numbers look good.
KPI #4: Competitive agility
Pharmaceutical markets are dynamic, and your launch strategy must be as well. How swiftly can your teams respond to new competitor data, or market signals? How effectively can you pivot your strategy in light of this new information? Competitive agility should be seen as a critical KPI, determining the resilience of your launch strategies in the face of change or unforeseen circumstances.
“It is imperative to not only track wins along the way but to intentionally engineer them. Start with the end in mind and then work backwards to determine critical milestones, leading indicators, and desired behaviors that will enable the ultimate goal.” –Pharmaceutical Commerce
KPI #5: Cross-functional alignment
The most successful pharma launches result from close alignment between leadership, commercial, and medical affairs teams. Are these departments working in silos – or aligned around shared intelligence and priorities? Is there an overarching strategy that informs decision-making across each department, and do departmental objectives ladder up to this shared strategy? Is there clear demarcation of departmental responsibilities, or is there some overlap?
“Achieving a cross-functional data strategy involves more than interoperability and advanced analytics. It demands an organizational mindset that values transparency, agility, and the strategic use of technology to accelerate insights.” -Jason Smith, CTO, AI & Analytics, Within3
In summary
If sales revenue is your sole KPI, you only see part of the picture. Revenue tells you how much was sold, but it won’t explain the factors behind performance – or whether that success is sustainable. Measuring additional KPIs like the five detailed above empowers you to answer critical questions, such as:
- Why was this launch a success?
- Which aspects of our strategy worked well, and which can be improved?
- What do patients and HCPs actually think about our organization and its products?
- Is this success repeatable?
If you’re tracking revenue alone, then you’re missing potential risks and opportunities down the line – and failing to take any tangible learnings from your successes (or otherwise). There are many other ways to measure launch excellence. A holistic KPI framework helps to demonstrate strategic value, accelerate decision-making, and de-risk launches – empowering you to achieve launch excellence.
Within3’s Launch Intelligence™ Platform features technologies such as social listening, network analytics, and insights reporting that help you track critical KPIs – and act on them. By turning data into direction, our platform empowers teams to improve continuously and achieve launch excellence year over year. Book a demo today to see for yourself.
